REVERSAL OF ABNORMAL RETINAL HEMODYNAMICS IN DIABETIC RATS BY ACARBOSE, AN ALPHA-GLUCOSIDASE INHIBITOR

被引:24
作者
TAKAGI, C [1 ]
KING, GL [1 ]
CLERMONT, AC [1 ]
CUMMINS, DR [1 ]
TAKAGI, H [1 ]
BURSELL, SE [1 ]
机构
[1] HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, JOSLIN DIABET CTR,DIV RES, BOSTON, MA 02215 USA
关键词
ACARBOSE; HEMODYNAMICS; RETINA; DIABETES; RATS;
D O I
10.3109/02713689508995795
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Acarbose is an inhibitor of intestinal alpha-glucosidase and has been reported to decrease blood glucose concentrations and glycosuria in diabetic patients and animals. In this study we investigated whether this drug could prevent the abnormalities detected in retinal circulation of diabetic rats. Longitudinal paired studies were performed and the changes in retinal circulation were analyzed using video based fluorescein angiography (VFA) methodology in the same animal. Baseline VFA recordings were obtained from 41 rats. These rats were separated into 4 different groups: In group A (n = 12), diabetes was induced by streptozotocin (STZ) injection and the rats were fed with acarbose (40 mg/100 g powdered chow) mixed into regular rat chow; In group B (n = 10), diabetes was induced by STZ injection and the rats were fed with normal chow; Tn group C (n = 9), the non-diabetic rats were fed with acarbose; In group D (n = 10), the non-diabetic rats were fed with normal chow. At the end of 2 weeks, all rats again underwent VFA recordings. Blood glucose levels and body weights of rats were monitored during the experiment. The mean blood glucose concentration of Group B was raised from 98.5 +/- 8.7 to 342 +/- 30 mg/dl after STZ injection while in Group A, this change in glucose level was partially ameliorated by acarbose (from 102 +/- 15 to 247 +/- 48 mg/dl). In Group C and D, the blood glucose levels were not significantly changed during the experiment. In Group B, a paired t-test analysis demonstrated that retinal blood flow in the untreated diabetic rats decreased significantly (p = 0.0001) 2 weeks after induction of diabetes (76.4 +/- 24.1 pixel(2)/s) compared to baseline (141.3 +/- 20.3 pixel(2)/s). In contrast, the acarbose treated diabetic rats in Group A showed no significant differences between blood flow before (140.1 +/- 21.6 pixel(2)/s) and after induction of diabetes (133.4 +/- 16.5 pixel(2)/s). There were no significant changes in retinal blood flow in the non-diabetic rat groups (Group C acarbose fed and Group D normal chow). These results suggest that acarbose can prevent the abnormalities detected in retinal circulation probably associated with decreasing the blood glucose concentration.
引用
收藏
页码:741 / 749
页数:9
相关论文
共 46 条
  • [1] ALDER VA, 1991, INVEST OPHTH VIS SCI, V32, P1028
  • [2] RETINAL MICROCIRCULATION IN PATIENTS WITH DIABETES-MELLITUS - DYNAMIC AND MORPHOLOGICAL ANALYSIS OF PERIFOVEAL CAPILLARY NETWORK
    AREND, O
    WOLF, S
    JUNG, F
    BERTRAM, B
    POSTGENS, H
    TOONEN, H
    REIM, M
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1991, 75 (09) : 514 - 518
  • [3] EFFECT OF ACUTE HYPERGLYCEMIA ON THE RETINAL CIRCULATION OF THE NORMAL CAT
    ATHERTON, A
    HILL, DW
    KEEN, H
    YOUNG, S
    EDWARDS, EJ
    [J]. DIABETOLOGIA, 1980, 18 (03) : 233 - 237
  • [4] Bischoff H, 1993, DRUG DEV, P3
  • [5] ESTIMATION OF RETINAL BLOOD FLOW BY MEASUREMENT OF MEAN CIRCULATION TIME
    BULPITT, CJ
    DOLLERY, CT
    [J]. CARDIOVASCULAR RESEARCH, 1971, 5 (03) : 406 - &
  • [6] EVALUATING RETINAL CIRCULATION USING VIDEO FLUORESCEIN ANGIOGRAPHY IN CONTROL AND DIABETIC RATS
    BURSELL, SE
    CLERMONT, AC
    SHIBA, T
    KING, GL
    [J]. CURRENT EYE RESEARCH, 1992, 11 (04) : 287 - 295
  • [7] CASPARY WF, 1978, LANCET, V1, P1231
  • [8] GLUCOSE CONTROL AND THE RENAL AND RETINAL COMPLICATIONS OF INSULIN-DEPENDENT DIABETES
    CHASE, HP
    JACKSON, WE
    HOOPS, SL
    COCKERHAM, RS
    ARCHER, PG
    OBRIEN, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (08): : 1155 - 1160
  • [9] CLERMONT A, 1993, INVEST OPHTH VIS SCI, V34, P1127
  • [10] CLERMONT A, 1992, INVEST OPHTH VIS SCI, V33, P1366